COP1 and ovarian carcinoma: KAT6A‐ΔIDR also induced resistance to cisplatin treatment by acetylating COP1 and stabilizing β‐catenin, similar to KAT6A‐WT in ovarian cancer cells[6] (Figure S2D,E, Supporting Information).